Detalles de la búsqueda
1.
Predicting survival of NSCLC patients treated with immune checkpoint inhibitors: Impact and timing of immune-related adverse events and prior tyrosine kinase inhibitor therapy.
Front Oncol
; 13: 1064169, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36860308
Resultados
1 -
1
de 1
1
Próxima >
>>